Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
aldosterona antagonisti,.
aldosterone antagonist.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
farmakoterapeitiskā grupa: aldosterona antagonisti.
pharmacotherapeutic group: aldosterone antagonist.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
telmisartāns pazemina aldosterona līmeni plazmā.
plasma aldosterone levels are decreased by telmisartan.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
aktivēta renīna-angiotensīna-aldosterona sistēma
activated renin-angiotensin-aldosterone system
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
zycortal lieto ilgtermiņā trūkstošā aldosterona aizstāšanai.
zycortal is used long-term to replace the missing aldosterone.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
divkārša renīna-angiotenzīna-aldosterona sistēmas blokāde
dual blockade of the renin-angiotensin-aldosterone system
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kardiovaskulārajā sistēmā spironolaktons profilaktē aldosterona nevēlamo ietekmi.
in the cardiovascular system, spironolactone prevents the detrimental effects of aldosterone.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Ārstēšanas laikā var novērot nelielu aldosterona līmeni asinīs.
a slight increase in aldosterone blood levels may be observed in animals on treatment.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
citi stāvokļi ar aktivizētu renīna-angiotenzīna-aldosterona sistēmu
other conditions with stimulation of the renin-angiotensin-aldosterone system
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
citi stāvokļi, kad aktivizēta renīna-angiotenzīna-aldosterona sistēma
other conditions with stimulation of the renin-angiotensin-aldosterone system
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
sirds-asinsvadu sistēmā spironolaktons aizkavē kaitīgo aldosterona ietekmi.
in the cardiovascular system, spironolactone prevents the detrimental effects of aldosterone.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
aldosterona deficīts var izraisīt šķidrumu zudumu, dehidratāciju un svara zudumu.
the lack of aldosterone can cause fluid loss, dehydration and weight loss.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bloķējot aldosterona iedarbību, spironolaktons palielina sāļu un ūdens izdalīšanos ar urīnu.
by blocking aldosterone, spironolactone increases the elimination of salt and water in the urine.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
aldosterona sekrēciju veicina ne tikai angiotenzīns ii, bet arī k+ pieaugums un akth.
secretion of aldosterone can also be stimulated by factors other than angiotensin-ii, notably k+ increase or acth.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Šāda iedarbība ir konstatēta arī citiem renīna-angiotensīna-aldosterona sistēmas inhibitoriem.
this effect is also seen with other inhibitors of the renin-angiotensin-aldosterone system.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
zāļu, kas ietekmē renīna-angiotenzīna-aldosterona sistēmu, lietošana var izraisīt hiperkaliēmiju.
the use of medicinal products that affect the renin-angiotensin-aldosterone system may cause hyperkalaemia.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
lietojot kombinācijā ar ace-inhibitoriem, spironolaktons var darboties pret „aldosterona noplūdes” efektu.
when used in combination with ace-inhibitors, spironolactone may counteract the effects of “aldosterone escape”.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
paaugstināts aldosterona līmenis (ūdens un sāls aizture organismā, kopā ar dažādu minerālvielu disbalansu asinīs).
raised aldosterone levels (water and salt retention in the body along with imbalance of various blood minerals).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pirms vienlaicīgas renīna-angiotenzīna-aldosterona sistēmu ietekmējošu zāļu lietošanas apsvēršanas jānovērtē ieguvuma un riska attiecība.
before considering the concomitant use of medicinal products that affect the renin-angiotensin- aldosterone system, the benefit risk ratio should be evaluated.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
selektīvs antagonisms pret angiotensīna ii (at1) receptoriem paaugstina renīna un angiotensīna ii līmeni plazmā un mazina aldosterona koncentrāciju plazmā.
the selective antagonism of the angiotensin-ii (at1) receptors results in increases in plasma renin levels and angiotensin-ii levels, and a decrease in plasma aldosterone concentration.
Last Update: 2017-04-26
Usage Frequency: 5
Quality: